Therapeutic inhibition of the miR-34 family attenuates pathological cardiac remodeling and improves heart function.

MLA

Bernardo, Bianca C., et al. “Therapeutic Inhibition of the MiR-34 Family Attenuates Pathological Cardiac Remodeling and Improves Heart Function.” Proceedings of the National Academy of Sciences of the United States of America, vol. 109, no. 43, Oct. 2012, pp. 17615–20. EBSCOhost, https://doi.org/10.1073/pnas.1206432109.

APA

Bernardo, B. C., Xiao-Ming Gao, Winbanks, C. E., Boey, E. J. H., Tham, Y. K., Kiriazis, H., Gregorevic, P., Obad, S., Kauppinen, S., Xiao-Jun Du, Lin, R. C. Y., & McMullen, J. R. (2012). Therapeutic inhibition of the miR-34 family attenuates pathological cardiac remodeling and improves heart function. Proceedings of the National Academy of Sciences of the United States of America, 109(43), 17615–17620. https://doi.org/10.1073/pnas.1206432109

Chicago

Bernardo, Bianca C., Xiao-Ming Gao, Catherine E. Winbanks, Esther J. H. Boey, Yow Keat Tham, Helen Kiriazis, Paul Gregorevic, et al. 2012. “Therapeutic Inhibition of the MiR-34 Family Attenuates Pathological Cardiac Remodeling and Improves Heart Function.” Proceedings of the National Academy of Sciences of the United States of America 109 (43): 17615–20. doi:10.1073/pnas.1206432109.